TOPICSSARS-CoV-2
SARS-CoV-2
Easy flu tests may enhance diagnosis and tracking
CRISPR assays for quick flu detection and subtyping.
Targeting various COVID variants by altering spike protein structure
Versatile antiviral nanoparticles, effective across SARS-CoV-2 variants.
First SARS-CoV-2 vaccinations immune response to new virus variants
Immunological imprinting impacts human antibody reaction to SARS-CoV-2 mutations.
MIT researchers are using new nanoparticles to improve vaccines
Zeolitic imidazolate frameworks boost SARS-CoV-2 spike protein trimer immunity via Toll-like receptor activation.
Iron deficiency from infection may trigger long COVID
Iron imbalance and inflammatory stress affect COVID-19 outcomes.
Current antiviral treatment course is inadequate for high-risk COVID-19
Molnupiravir's impact on SARS-CoV-2 response in at-risk outpatients.
SARS-CoV-2 variants: How a set of key covariates affect viral kinetics?
A prospective observational cohort study.
Breakthrough RNA mapping method by HIRI researchers
SHIFTR allows unbiased protein identification on RNA regions in live cells.
The complement system damages cells in long-term COVID
Persistent complement dysfunction in long COVID: Inflammation and blood clot risks.
Influenza immunity spurs rapid protection in new vaccine
Influenza boosts antibody power against SARS-CoV-2.
How ultraviolet light degrades coronavirus?
SARS-CoV-2 has among the largest of genomes for RNA viruses.
COVID-19 changes gene activity in olfactory mucosal cells in Alzheimer’s
Distinct immune responses after infection between AD patients and healthy individuals.